Advanced search
Publication Cover
Risk Management and Healthcare Policy Volume 16, 2023 - Issue
Submit an article Journal homepage
150
Views
0
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

Identification of the Genotypes Circulating in the Ecuadorian Population Infected with the Hepatitis C Virus (HCV)

Miguel Moncayo1 Instituto de Microbiología, Universidad San Francisco de Quito USFQ, Quito, Ecuador;2 Laboratorio Clinico Pasteur Dr. Alberto Moncayo Calero, Quito, EcuadorView further author information
,
Enrique Teran1 Instituto de Microbiología, Universidad San Francisco de Quito USFQ, Quito, Ecuador;3 Colegio de Ciencias de la Salud, Universidad San Francisco de Quito USFQ, Quito, EcuadorORCID Iconhttps://orcid.org/0000-0001-6979-5655View further author information
ORCID Icon,
Jorge Reyes4 Facultad de Ciencias Químicas, Universidad Central del Ecuador, Quito, Ecuador;5 Departamento de Microbiologı´a, Hospital del IESS Quito Sur, Quito, EcuadorORCID Iconhttps://orcid.org/0000-0002-5215-164XView further author information
ORCID Icon,
Gabriela Yerovi6 Ministerio de Salud Pública del Ecuador, Quito, EcuadorView further author information
,
Marcia Robalino6 Ministerio de Salud Pública del Ecuador, Quito, EcuadorView further author information
,
Ana Cristina Aguilar1 Instituto de Microbiología, Universidad San Francisco de Quito USFQ, Quito, Ecuador;3 Colegio de Ciencias de la Salud, Universidad San Francisco de Quito USFQ, Quito, EcuadorORCID Iconhttps://orcid.org/0000-0001-7519-1583View further author information
ORCID Icon &
Daniel Garzon-Chavez1 Instituto de Microbiología, Universidad San Francisco de Quito USFQ, Quito, Ecuador;3 Colegio de Ciencias de la Salud, Universidad San Francisco de Quito USFQ, Quito, EcuadorCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0002-8024-3509View further author information
ORCID Icon show all
Pages 1403-1409 | Received 04 Apr 2023, Accepted 08 Jul 2023, Published online: 03 Aug 2023

References

  • Tellinghuisen TL, Rice CM. The molecular virology of hepatitis C virus. Princ Med Biol. 2004;15(C):455–495.
  • Qiu P, Cai XY, Wang L, Greene JR, Malcolm B. Hepatitis C virus whole genome position weight matrix and robust primer design. BMC Microbiol. 2002;2:1–7. doi:10.1186/1471-2180-2-29
  • Tsukiyama-Kohara K, Kohara M. Hepatitis C virus: viral quasispecies and genotypes. Int J Mol Sci. 2018;19(1):1–8.
  • World Health Organization. Hepatitis C. World Health Organization; 2021. Available from: https://www.who.int/news-room/fact-sheets/detail/hepatitis-c. Accessed July 17, 2023.
  • Petruzziello A, Marigliano S, Loquercio G, Cozzolino A, Cacciapuoti C. Global epidemiology of hepatitis C virus infection: an update of the distribution and circulation of hepatitis C virus genotypes. World J Gastroenterol. 2016;22(34):7824–7840. doi:10.3748/wjg.v22.i34.7824
  • Blach S, Zeuzem S, Manns M, et al. Global prevalence and genotype distribution of hepatitis C virus infection in 2015: a modeling study. Lancet Gastroenterol Hepatol. 2017;2(3):161–176. doi:10.1016/S2468-1253(16)30181-9
  • Messina JP, Humphreys I, Flaxman A, et al. Global distribution and prevalence of hepatitis C virus genotypes. Hepatology. 2015;61(1):77–87. doi:10.1002/hep.27259
  • Ghany MG, Morgan TR; AASLD‐IDSA Hepatitis C Guidance Panel. Hepatitis C guidance 2019 update: American Association for the study of liver diseases-Infectious Diseases Society of America Recommendations for testing, managing, and treating hepatitis C virus infection. Hepatology. 2020;71(2):686–721. doi:10.1002/hep.31060
  • Tong YQ, Liu B, Liu H, et al. Accurate genotyping of hepatitis C virus through nucleotide sequencing and identification of new HCV subtypes in China population. Clin Microbiol Infect. 2015;21(9):874.e9–874.e21. doi:10.1016/j.cmi.2015.05.034
  • Santos Ó, Gómez A, Vizcaíno V, et al. Genotipos circulantes del virus de la hepatitis C en Colombia. Biomedica. 2017;37(1):22–27. doi:10.7705/biomedica.v37i1.3173
  • Sanchez JL, Abdel-Hamid M, Callahan JD, et al. Hepatitis C in Peru: risk factors for infection, potential iatrogenic transmission, and genotype distribution. Am J Trop Med Hyg. 2000;63(5):242–248. doi:10.4269/ajtmh.2000.63.242
  • Imbeth-Acosta P, Leal-Martínez V, Ramos-Clason E, et al. Prevalence of chronic infection by hepatitis C virus in asymptomatic population with risk factors in Cartagena, Colombia. Front Med. 2022;9:1–6. doi:10.3389/fmed.2022.814622
  • Maaroufi A, Vince A, Himatt SM, et al. Historical epidemiology of hepatitis C virus in select countries—volume 4. J Viral Hepat. 2017;24:8–24. doi:10.1111/jvh.12762
  • Farfán G, Cabezas C. Prevalence of viral hepatitis type C in blood donors in Peru. Revista de gastroenterología del Perú. 2003;23(3):171–176.
  • Grijalva MJ, Chiriboga RF, Vanhassel H, et al. Improving the safety of the blood supply in Ecuador through external performance evaluation of serological screening of blood donors. J Clin Virol. 2005;34(SUPPL. 2):S47–S52. doi:10.1016/S1386-6532(05)80034-4
  • Spengler U. Direct antiviral agents (DAAs) - A new age in the treatment of hepatitis C virus infection. Pharmacol Ther. 2018;183:118–126. doi:10.1016/j.pharmthera.2017.10.009
  • Jakobsen JC, Nielsen EE, Feinberg J, et al. Direct-acting antivirals for chronic hepatitis C. Cochrane Database Syst Rev. 2017;2017(6):154.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.